With every assignment, we commit to truly understand our client’s needs and circumstances,

assemble a team optimized to tackle the challenge at hand, and generate superior, timely results. 

 

At Popper and Company, we are selective about the assignments we undertake, seeking those where we believe our team can efficiently add value and where the nature of the project challenges us to be our very best.

IT Company Life Sciences Strategy

We helped a multinational, Silicon Valley-based information technology company translate their technology offering to the life sciences market and develop a roadmap to commercialize their offering.

Clinical Diagnostics Business Acceleration

We helped an international developer of clinical and diagnostic technology develop and implement a regulatory strategy that resulted in a 510(k) de novo submission to the FDA.

 
 

Cost-in-Use Analysis

We helped an emerging device company with pricing strategy and constructed a quantitative cost-in-use model to enable prospective customers to appropriately assess the value of our client’s device.

Molecular Diagnostics Commercialization

We helped an international, venture-backed diagnostics company identify and rank market opportunities for their point-of-care testing solutions and commercialize their offerings.

 
 

Pharmaceutical Co. Market Strategy

We helped a leading multinational pharmaceutical and diagnostic company define their cancer diagnostics capabilities and identify opportunities for expansion into the precision medicine market.

Medical Center Transaction Advisory

We helped a premier academic health science center identify potential partners and enter into a joint venture with a global clinical diagnostics and laboratory testing service provider.

 
 

Pharmaceutical Co. Due Diligence

We helped a leading multinational pharmaceutical and diagnostic company understand the molecular diagnostics landscape and identify the risks and opportunities of a potential strategic transaction.